336 related articles for article (PubMed ID: 29927498)
1. Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits.
Ohtsuki M; Morimoto H; Nakagawa H
J Dermatol; 2018 Aug; 45(8):936-942. PubMed ID: 29927498
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA
BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134
[TBL] [Abstract][Full Text] [Related]
3. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
Frankel HC; Qureshi AA
Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
[TBL] [Abstract][Full Text] [Related]
5. Topical tacrolimus in adult atopic dermatitis: a consensus based on a 15-year experience.
Calzavara-Pinton P; Fabbrocini G; Girolomoni G; Matiucci A; Micali G; Musumeci ML; Patruno C; Pellacani G; Rossi MT; Castello M; Stingeni L
G Ital Dermatol Venereol; 2020 Feb; 155(1):8-13. PubMed ID: 31760730
[TBL] [Abstract][Full Text] [Related]
6. Calcineurin inhibitors in pediatric atopic dermatitis: a review of current evidence.
Kalavala M; Dohil MA
Am J Clin Dermatol; 2011 Feb; 12(1):15-24. PubMed ID: 21067248
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
Cheer SM; Plosker GL
Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
[TBL] [Abstract][Full Text] [Related]
8. Safety of topical medications in the management of paediatric atopic dermatitis: An updated systematic review.
Zhao S; Hwang A; Miller C; Lio P
Br J Clin Pharmacol; 2023 Jul; 89(7):2039-2065. PubMed ID: 37075252
[TBL] [Abstract][Full Text] [Related]
9. The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis.
McCollum AD; Paik A; Eichenfield LF
Pediatr Dermatol; 2010; 27(5):425-36. PubMed ID: 20678096
[TBL] [Abstract][Full Text] [Related]
10. The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.
Rustin MH
Br J Dermatol; 2007 Nov; 157(5):861-73. PubMed ID: 17854353
[TBL] [Abstract][Full Text] [Related]
11. Topical [symbol: see text] tacrolimus--a role in atopic dermatitis?
Drug Ther Bull; 2002 Oct; 40(10):73-5. PubMed ID: 12434738
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety of tacrolimus ointment in atopic dermatitis.
Remitz A; Reitamo S
Expert Opin Drug Saf; 2009 Jul; 8(4):501-6. PubMed ID: 19435404
[TBL] [Abstract][Full Text] [Related]
13. Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.
Luger T; Boguniewicz M; Carr W; Cork M; Deleuran M; Eichenfield L; Eigenmann P; Fölster-Holst R; Gelmetti C; Gollnick H; Hamelmann E; Hebert AA; Muraro A; Oranje AP; Paller AS; Paul C; Puig L; Ring J; Siegfried E; Spergel JM; Stingl G; Taieb A; Torrelo A; Werfel T; Wahn U
Pediatr Allergy Immunol; 2015 Jun; 26(4):306-15. PubMed ID: 25557211
[TBL] [Abstract][Full Text] [Related]
14. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
Hebert AA
Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
[TBL] [Abstract][Full Text] [Related]
15. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas.
Draelos ZD
Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804
[TBL] [Abstract][Full Text] [Related]
16. An approach to pruritus in atopic dermatitis: a critical systematic review of the tacrolimus ointment literature.
Fleischer AB; Boguniewicz M
J Drugs Dermatol; 2010 May; 9(5):488-98. PubMed ID: 20480792
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of Topical Corticosteroids and Topical Calcineurin Inhibitors for the Treatment of Atopic Dermatitis.
Pena J; Zameza PA; Pixley JN; Remitz A; Feldman SR
J Allergy Clin Immunol Pract; 2023 May; 11(5):1347-1359. PubMed ID: 36997119
[TBL] [Abstract][Full Text] [Related]
18. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.
Kawakami T; Soma Y; Morita E; Koro O; Yamamoto S; Nakamura K; Tamaki K; Yajima K; Imaizumi A; Matsunaga R; Murakami N; Kashima M; Mizoguchi M
Dermatology; 2001; 203(1):32-7. PubMed ID: 11549797
[TBL] [Abstract][Full Text] [Related]
19. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
20. Unmet medical needs in the treatment of atopic dermatitis in infants: An Expert consensus on safety and efficacy of pimecrolimus.
Luger T; Augustin M; Lambert J; Paul C; Pincelli C; Torrelo A; Vestergaard C; Wahn U; Werfel T
Pediatr Allergy Immunol; 2021 Apr; 32(3):414-424. PubMed ID: 33251600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
